927 related articles for article (PubMed ID: 30661654)
1. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
[TBL] [Abstract][Full Text] [Related]
2. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
[TBL] [Abstract][Full Text] [Related]
5. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Syn NL; Yong WP; Goh BC; Lee SC
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
[TBL] [Abstract][Full Text] [Related]
6. How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care.
Cipri S; Abenavoli L; Boccuto L; Del Baldo G; Mastronuzzi A
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295546
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
[TBL] [Abstract][Full Text] [Related]
8. Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences.
Cho M; Ahn S; Hong M; Bang H; Van Vrancken M; Kim S; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK; Sun JM; Lee SH; Ahn MJ; Park K; Kim DH; Lee S; Park W; Kim KM
Oncotarget; 2017 Jun; 8(26):42478-42486. PubMed ID: 28477007
[TBL] [Abstract][Full Text] [Related]
9. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
Lih CJ; Takebe N
Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
[TBL] [Abstract][Full Text] [Related]
10. [Cancer: three eras of personalized medicine].
Jordan B
Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
[TBL] [Abstract][Full Text] [Related]
11. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.
Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS
BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing of cancer genomes: lessons learned.
Corrigan AE; Taylor R; Rallis KS
Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
[No Abstract] [Full Text] [Related]
13. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
14. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types.
Shu Y; Wu X; Tong X; Wang X; Chang Z; Mao Y; Chen X; Sun J; Wang Z; Hong Z; Zhu L; Zhu C; Chen J; Liang Y; Shao H; Shao YW
Sci Rep; 2017 Apr; 7(1):583. PubMed ID: 28373672
[TBL] [Abstract][Full Text] [Related]
16. Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.
Allegretti M; Fabi A; Buglioni S; Martayan A; Conti L; Pescarmona E; Ciliberto G; Giacomini P
J Exp Clin Cancer Res; 2018 Mar; 37(1):47. PubMed ID: 29506529
[TBL] [Abstract][Full Text] [Related]
17. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
[TBL] [Abstract][Full Text] [Related]
18. Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.
Hicks JK; Saller J; Wang E; Boyle T; Gray JE
Lung Cancer; 2017 Sep; 111():135-138. PubMed ID: 28838384
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing in precision oncology: challenges and opportunities.
Kruglyak KM; Lin E; Ong FS
Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of amplicon-based next-generation sequencing in cancer.
Chang F; Li MM
Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
